Effect of ghrelin and metoclopramide on prolactin secretion in normal women

Journal of Endocrinological Investigation

Volumn 34, Issue 4, 2011, Pages 276-279

  Messini, C I ^a   Dafopoulos, K ^a   Chalvatzas, N ^a   Georgoulias, P ^a   Anifandis, G ^a   Messinis, I E ^a  

^a UNIVERSITY OF THESSALY   (Greece)

Author keywords

Dopamine; GH; Ghrelin; Metoclopramide; PRL; Women

Indexed keywords

CLINALFA; ESTRADIOL; FOLLITROPIN; GHRELIN; LUTEINIZING HORMONE; METOCLOPRAMIDE; PROGESTERONE; PROLACTIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CYCLING; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; HUMAN; LUTEAL PHASE; LUTEINIZING HORMONE BLOOD LEVEL; MENSTRUAL CYCLE; MULTIPLE CYCLE TREATMENT; NORMAL HUMAN; OUTCOME ASSESSMENT; OVULATION; PREGNANCY OUTCOME; PROGESTERONE BLOOD LEVEL; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE;

ADULT; DOPAMINE ANTAGONISTS; FEMALE; GHRELIN; HUMANS; MENSTRUAL CYCLE; METOCLOPRAMIDE; PROLACTIN; RADIOIMMUNOASSAY; YOUNG ADULT;

EID: 79957953874     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/7102     Document Type: Article

References (37)

1. Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402: 656-60. (Pubitemid 129516334)
2. Soares JB, Leite-Moreira AF. Ghrelin, des-acyl ghrelin and obestatin: three pieces of the same puzzle. Peptides 2008, 29: 1255-70.
3. Takaya K, Ariyasu H, Kanamoto N, et al. Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab 2000, 85: 4908-11. (Pubitemid 32157685)
4. Hataya Y, Akamizu T, Takaya K, et al. A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans. J Clin Endocrinol Metab 2001, 86: 4552-5. (Pubitemid 32848588)
5. Villa P, Costantini B, Perri C, Suriano R, Ricciardi L, Lanzone A. Estro-progestin supplementation enhances the growth hormone secretory responsiveness to ghrelin infusion in postmenopausal women. Fertil Steril 2008, 89: 398-403. (Pubitemid 351215392)
6. Messini CI, Dafopoulos K, Chalvatzas N, Georgoulias P, Messinis IE. Effect of ghrelin on gonadotrophin secretion in women during the menstrual cycle. Hum Reprod 2009, 24: 976-81.
7. Messini CI, Dafopoulos K, Chalvatzas N, Georgoulias P, Messinis IE. Growth hormone and prolactin response to ghrelin during the normal menstrual cycle. Clin Endocrinol 2009, 71: 383-7.
8. Arvat E, Maccario M, Di Vito L, et al. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J Clin Endocrinol Metab 2001, 86: 1169-74. (Pubitemid 32323000)
9. Schmid DA, Held K, Ising M, Uhr M, Weikel JC, Steiger A. Ghrelin stimulates appetite, imagination of food, GH, ACTH, and cortisol, but does not affect leptin in normal controls. Neuropsychopharmacology 2005, 30: 1187-92. (Pubitemid 40720978)
10. Fusco A, Bianchi A, Mancini A, et al. Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome. J Endocrinol Invest 2007, 30; 948-56. (Pubitemid 351350831)
11. Alvarez-Castro, P, Isidro ML, Garcia-Buela J, et al. Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients. Clin Endocrinol 2004, 61: 250-5. (Pubitemid 39093122)
12. Guido M, Romualdi D, De Marinis L, et al. Administration of exogenous ghrelin in obese patients with polycystic ovary syndrome: effects on plasma levels of growth hormone, glucose, and insulin. Fertil Steril 2007, 88: 125-30. (Pubitemid 47001394)
13. Broglio F, Gianotti L, Destefanis S, et al. The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state. Clin Endocrinol 2004, 60: 592-9. (Pubitemid 38669849)
14. Fassino S, Daga GA, Mondelli V, et al. Hormonal and metabolic responses to acute ghrelin administration in patients with bulimia nervosa. Psychoneuroendocrinology 2005, 30: 534-40. (Pubitemid 40461787)
15. Kok P, Paulo RC, Cosma M, et al. Estrogen supplementation selectively enhances hypothalamo-pituitary sensitivity to ghrelin in postmenopausal women. J Clin Endocrinol Metab 2008, 93: 4020-6.
16. Rubinfeld H, Hadani M, Taylor JE, et al. Novel ghrelin analogs with improved affinity for the GH secretagogue receptor stimulate GH and prolactin release from human pituitary cells. Eur J Endocrinol. 2004, 151: 787-95. (Pubitemid 40090020)
17. Messini CI, Dafopoulos K, Chalvatzas N, Georgoulias P, Anifandis G, Messinis IE. Blockage of ghrelin-induced prolactin secretion in women by bromocriptine. Fertil Steril 2010, 94: 1478-81.
18. Judd SJ, Lazarus L, Smythe G. Prolactin secretion by metoclopramide in man. J Clin Endocrinol Metab 1976, 43: 313-7.
19. Cunha-Filho JS, Gross JL, Vettori D, Dias EC, Passos EP. Growth hormone and prolactin secretion after metoclopramide administration (DA2 receptor blockade) in fertile women. Horm Metab Res 2001, 33: 536-9. (Pubitemid 32928090)
20. del Pozo E, Brownell J. Prolactin. I. Mechanisms of control, peripheral actions and modification by drugs. Horm Res 1979, 10: 143-74. (Pubitemid 9131867)
21. Reymond MJ, Porter JC. Involvement of hypothalamic dopamine in the regulation of prolactin secretion. Horm Res 1985, 22: 142-52. (Pubitemid 15239624)
22. Ben-Jonathan N, Hnasko R. Dopamine as a prolactin (PRL) inhibitor. Endocr Rev 2001, 22: 724-63. (Pubitemid 34214293)
23. Hirvonen E, Ranta T, Seppala M. Prolactin and thyrotropin responses to thyrotropin-releasing hormone in patients with secondary amenorrhea: the effect of bromocriptine. J Clin Endocrinol Metab 1976, 42: 1024-30.
24. Andreassen B, Huth J, Tyson JE. Plasma thyrotropin-releasing hormone, prolactin, thyrotropin, and thyroxine concentrations following the intravenous or oral administration of thyrotropin-releasing hormone. Am J Obstet Gynecol 1979, 135: 737-42. (Pubitemid 10236397)
25. Kauppila A, Ylikorkala O. Effects of oral and intravenous TRH and metoclopramide on PRL and TSH secretion in women. Clin Endocrinol 1982, 17: 617-23. (Pubitemid 12006969)
26. Veldhuis JD, Keenan DM, Iranmanesh A, Mielke K, Miles JM, Bowers CY. Estradiol potentiates ghrelin-stimulated pulsatile growth hormone secretion in postmenopausal women. J Clin Endocrinol Metab 2006, 91: 3559-65. (Pubitemid 44402138)
27. Messinis IE, Lolis DE, Dalkalitsis N, Kanaris C, Souvatzoglou A. Effect of metoclopramide on maternal and fetal prolactin secretion during labor. Obstet Gynecol 1982, 60: 686-8. (Pubitemid 13234438)
28. Login IS, Judd AM, Kuan SI, MacLeod RM. Role of calcium in dopaminergic regulation of TRHand angiotensin II-stimulated prolactin release. Am J Physiol 1991, 260: E553-60.
29. Cui ZJ, Gorelick FS, Dannies PS. Calcium/calmodulin-dependent protein kinase-II activation in rat pituitary cells in the presence of thyrotropin-releasing hormone and dopamine. Endocrinology 1994, 134: 2245-50. (Pubitemid 24142969)
30. Martínez de la Escalera G, Guthrie J, Weiner RI. Transient removal of dopamine potentiates the stimulation of prolactin release by TRH but not VIP: stimulation via Ca2+/protein kinase C pathway. Neuroendocrinology 1988, 47: 38-45. (Pubitemid 18001543)
31. Ho KY, Smythe GA, Lazarus L. The interaction of trh and dopaminergic mechanisms in the regulation of stimulated prolactin release in man. Clin Endocrinol (Oxf) 1985, 23: 7-16. (Pubitemid 15042143)
32. Hanew K, Utsumi A, Sugawara A, Shimizu Y, Yoshinaga K. Simultaneous administration of TRH and sulpiride caused additive but not synergistic PRL responses in normal subjects. Endocrinol Jpn 1992, 39: 465-8. (Pubitemid 23141978)
33. Nishina Y, Takano K, Yasufuku-Takano J, Teramoto A, Fujita T. Mechanism of D(2) agonist-induced inhibition of GH secretion from human GH-secreting adenoma cells. Endocr J 2005, 52: 775-9.
34. Colao A, Filippella M, Pivonello R, Di Somma C, Faggiano A, Lombardi G. Combined therapy of somatostatin analogues and dopamine agonists in the treatment of pituitary tumours. Eur J Endocrinol 2007, 156 (Suppl 1): S57-63.
35. Kok P, Roelfsema F, Frölich M, van Pelt J, Meinders AE, Pijl H. Short-term treatment with bromocriptine improves impaired circadian growth hormone secretion in obese premenopausal women. J Clin Endocrinol Metab 2008, 93: 3455-61.
36. Yang H, Dixit VD, Patel K, Vandanmagsar B, Collins G, Sun Y, Smith RG, Taub DD. Reduction in hypophyseal growth hormone and prolactin expression due to deficiency in ghrelin receptor signaling is associated with Pit-1 suppression: relevance to the immune system. Brain Behav Immun 2008, 22: 1138-45.
37. Seki K, Nagata T. Effects of a dopamine antagonist (metoclopramide) on the release of LH, FSH, TSH and PRL in normal women throughout the menstrual cycle. Acta Endocrinol (Copenh) 1990, 122: 211-6. (Pubitemid 20068295)